After completion of its mandatory tender offer in Fortis Healthcare and Fortis Malar Hospitals, Malaysian health care giant IHH Healthcare is aiming to add 2,000 beds in a bid to double down on value creation in India. IHH, which is Asia's largest multinational private healthcare provider, currently has over 5,000 beds across a combined network of 35 hospitals and 11 states.
'It interferes in administrative matters of institutions, robbing them of their independence in day-to-day affairs and appointments.'
Brookfield Asset Management will invest $1 billion to develop Asia's largest global capability centre (GCC) in Mumbai's Powai, the New York-based global alternative asset manager said in a statement on Friday. The infrastructure arm of Canada's investment firm will develop the campus across 6 acres with 2 million square feet that can be let out.
The semaglutide patent expiry next year could unleash a wave of generic versions from Indian drugmakers, with prices expected to go lower -- at least 80 per cent.
Ghost malls have a vacancy rate of over 50 per cent.
University College London has recorded a 19 per cent and 26 per cent rise in undergraduate and postgraduate students from India for the 2026 term, indicating a preference for the UK over the US at a time when Indian students are facing visa uncertainties in US-based institutions.
Experts said that earmarking of funds for public health at par with national security indicates a key policy shift.
Several IITs have been pushing for a diversification of job profiles as roles move beyond just tech companies and start-ups, particularly with the advent of AI.
Top real estate developers reported healthy presales growth in the second quarter of FY26, aided by a steady pipeline of new project launches. While overall housing momentum across major Indian cities moderated during the quarter, listed players remained relatively insulated.
The government aims to cover around 60 million people in the age category, irrespective of income, with an assured 5 lakh annually to be shared within the family.
India's top cement producers delivered a solid July-September quarter (Q2) in 2025-26 (FY26), lifted by firmer prices, higher sales volumes, and a favourable base. Seasonal weakness and maintenance outages did dent sequential performance, but the overall picture remained positive - and the road ahead looks steady.
Affordable homes, priced under Rs 40 lakh per unit, may not be attractive anymore, not just for developers but also for investors, with the segment seeing a 26 per cent price rise over three years since 2022 versus 40 per cent returns from luxury homes priced Rs 1.5 crore and above.
Since their inception, they have cumulatively distributed over Rs 26,700 crore to unitholders.
High-street rentals continue to outpace those of malls, as retailers focus on prime locations and are willing to pay a premium for visibility. Between 2021 and 2025, rental values on prime high street have grown 7-15 per cent annually, driven by strong consumption density and limited new supply, even outpacing grade A malls, which grew by 5-8 per cent, according to Anarock.
The clinics are expected to operate for at least two hours daily, particularly between September and March -- the period when air pollution levels are typically high.
The Supreme Court has said that selling land or property is not a service under the Finance Act, 1994, so such sales cannot be charged with service tax.
'Earlier, such beliefs were primarily observed among older buyers, but now we see younger buyers showing interest in aligning purchases with numerological or astrological significance.'
In the academic year 2024-2025, the IB had 258 authorised schools in India, up from 183 schools in 2019.
At present, there is no provision under Drugs Rules, 1945 to address issues of wrong information to obtain regulatory approvals.
Interest in green living is rising, with clean air and open spaces becoming key selling points for residential projects, particularly as Indian cities struggle with deteriorating air quality.
© 2025 Rediff.com - Investor Information - Advertise with us - Disclaimer - Privacy Policy - Sitemap - Feedback - About us - Terms of use - Grievances